COVID-19 Vaccines Seem Safe in Rheumatic, Musculoskeletal Disease Patients
Disease flare requiring treatment reported in 11 percent following two-dose mRNA SARS-CoV-2 vaccination, with no reports of severe flare
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.